Pelago
PrivateLast Round
Series C
Mar 28, 2024
Total Funding Raised
$135.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pelago operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series C round in March 2024.
Pelago is a healthcare technology company that offers a virtual clinic platform providing personalized, digital-first substance use management and treatment services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pelago Comparables
Compare Pelago with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affect Therapeutics | 85% | |
| Ria Health | 84% | |
| Workit Health | 84% |
For institutional investors. Book with your work email.
Pelago Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 28, 2024 | ||||
| Series B | Jul 19, 2021 | ||||
| Series A | Mar 19, 2020 | ||||
| Seed | Mar 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pelago Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Force Over Mass | Seed |
| Eight Roads Ventures | Series C |
| Triple Point Ventures | Series A, Series B |
| Village Global | Seed |
| Pioneer Fund | Seed |
| Y Combinator | Seed, Series A, Series C |
| StartUp Health | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
Company holds HITRUST certification.
- Oct 8, 2026
Company holds SOC 2 Type II certification.
For institutional investors. Book with your work email.
Pelago Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pelago's valuation, stock price, and market status.
Is Pelago a public or private company?
Pelago is a private company.
What is the current stock price of Pelago?
Pelago is a private company, so its shares have no public market price. Caplight tracks Pelago's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pelago worth (valuation)?
Valuation information for Pelago is not publicly available.
Can I buy Pelago stock?
Pelago shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pelago's last funding round?
Pelago's most recent funding round was Series C on March 28, 2024.
Who are the main investors in Pelago?
Key investors in Pelago include Atomico, Octopus Investments, Octopus Ventures, Kinnevik, Octopus Labs.
Will Pelago IPO soon?
No public IPO plans have been announced for Pelago.
How can I track Pelago secondary market activity?
Caplight tracks bids, offers, and trades in Pelago's shares on secondary markets.